Anne-Marie Rasmussen

Title: Anne-Marie Rasmussen: Innovator in Cancer Treatment

Introduction

Anne-Marie Rasmussen is a prominent inventor based in Oslo, Norway. She has made significant contributions to the field of cancer treatment through her innovative research and development of vaccines. With a total of 4 patents to her name, she is recognized for her dedication to advancing medical science.

Latest Patents

One of her latest patents includes a telomerase polypeptide vaccine for treating cancer. This polypeptide comprises the sequence of SEQ. ID NO. 2, 3, 4, 7, or 8. The polypeptide may also have the sequence of an immunogenic fragment comprising at least eight amino acids, with specific exclusions for certain sequences. It is designed to be less than 100 amino acids in length and is useful in the treatment or prophylaxis of cancer.

Career Highlights

Throughout her career, Anne-Marie has worked with notable companies such as Ultimovacs and Life Technologies. Her work in these organizations has allowed her to further her research and contribute to the development of innovative cancer therapies.

Collaborations

Anne-Marie has collaborated with esteemed colleagues, including Else Marit Inderberg Suso and Gustav Gaudernack. These partnerships have played a crucial role in her research endeavors and have helped to enhance the impact of her work.

Conclusion

Anne-Marie Rasmussen is a trailblazer in the field of cancer treatment, with a focus on developing innovative vaccines. Her contributions and collaborations continue to shape the future of medical science.